Niki BioSolutions' DiamiR Biosciences To Present Poster At 19th Clinical Trialns On Alzheimer's Disease Conference
Benzinga Newsdesk 12 hours ago
News
Niki BioSolutions, Inc. (NASDAQ:NIKI) ("Niki BioSolutions" or the "Company"), a clinical-stage life sciences company focused on developing advanced genomic and biomarker testing solutions, today
Niki BioSolutions, Inc. (NASDAQ:NIKI) ("Niki BioSolutions" or the "Company"), a clinical-stage life sciences company focused on developing advanced genomic and biomarker testing solutions, today announced that its wholly owned subsidiary, DiamiR Biosciences Corp. ("DiamiR"), will be presenting a poster at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) conference on Wednesday, November 19th, in Boston, MA.